Larvol Delta - A-Phase-I-DoseEscalation-and-DoseExpansion-Study-of-FCN437c-a-Novel-CDK46-Inhibitor-in-Patients-with-Advanced-Solid-Tumors

FCN-437 - Fosun Pharma

http://www.ncbi.nlm.nih.gov/pubmed/36291780

Oct 28, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next